FATE THERAPEUTICS DL-,001 revenue breakdown overview

FATE THERAPEUTICS DL-,001 revenue for the last year amounted to 57.56 M EUR, the most of which — 57.56 M EUR — came from its highest performing source at the moment, Cellular Immunotherapies, the year earlier bringing 89.98 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought FATE THERAPEUTICS DL-,001 57.56 M EUR, and the year before that — 89.98 M EUR.